Shares of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Get Free Report) have earned a consensus recommendation of “Buy” from the five research firms that are presently covering the firm, MarketBeat ...

UBS Group lifted their price objective on Mplx from $51.00 to $55.00 and gave the stock a “buy” rating in a research report ...

Lamosaic India, operating in the Plywood/Laminates sector and classified as a Smallcap on the nse, currently has its share price at 172.2 The stock has experienced fluctuations today, with a low of ...

Right here, at Page Six! If you’re in the market for celebrity-worthy styles on a budget, luxury beauty and skincare for less ...